Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Bruker shares jump as new ASMS launches spotlight proteomics, energy, and semiconductor demand

None

Bruker Corporation (BRKR) is up 9.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to upbeat reception for Bruker’s new mass spectrometry and proteomics announcements unveiled around the ASMS conference, including disclosures that point to strengthening commercial demand in semiconductor manufacturing. The rally may also reflect investors extending momentum from the company’s recent quarter, where results exceeded expectations and management maintained full-year targets.

Details:

  • Bruker highlighted major performance advances in 4D proteomics workflows, including claims of protein identifications and quantification surpassing 10,000 proteins per sample in certain settings, supported by instrument upgrades and software updates.
  • The company introduced the timsMRMS platform combining trapped ion mobility with ultra-high-resolution magnetic resonance mass spectrometry, positioning it for ultra-complex mixture analysis across energy applications such as petroleomics, biofuels, and battery research.
  • Bruker disclosed a multi-million-dollar, multiple-systems order for airborne molecular contaminants TOF-MS solutions from a leading global memory manufacturer, pointing to traction in semiconductor yield-optimization workflows.
  • In its most recent quarterly update, Bruker posted an earnings beat and reiterated its full-year outlook, which can amplify upside sensitivity when fresh product and order headlines hit.
  • Sources:

    Business Wire, MarketBeat, TradingView

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $BRKR Insider Trading Activity

    BRKR Insider Trades

    $BRKR insiders have traded $BRKR stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

    Here’s a breakdown of recent trading of $BRKR stock by insiders over the last 6 months:

    • MARK MUNCH (EXEC VP&PRES BRUKER NANO INC.) has made 0 purchases and 4 sales selling 13,000 shares for an estimated $634,080.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    EARLY ACCESS
    Receive BRKR Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $BRKR Hedge Fund Activity

    We have seen 178 institutional investors add shares of $BRKR stock to their portfolio, and 229 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $BRKR Government Contracts

    We have seen $17,113,800 of award payments to $BRKR over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

    $BRKR Analyst Ratings

    Wall Street analysts have issued reports on $BRKR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

    Here are some recent analyst ratings:

    • B of A Securities issued a "Buy" rating on 12/15/2025
    • Goldman Sachs issued a "Sell" rating on 12/09/2025

    To track analyst ratings and price targets for $BRKR, check out Quiver Quantitative's $BRKR forecast page.

    $BRKR Price Targets

    Multiple analysts have issued price targets for $BRKR recently. We have seen 11 analysts offer price targets for $BRKR in the last 6 months, with a median target of $50.0.

    Here are some recent targets:

    • Luke Sergott from Barclays set a target price of $53.0 on 05/07/2026
    • Patrick Donnelly from Citigroup set a target price of $44.0 on 05/07/2026
    • Dan Leonard from UBS set a target price of $45.0 on 05/07/2026
    • Kyle Boucher from TD Cowen set a target price of $45.0 on 05/07/2026
    • Subbu Nambi from Guggenheim set a target price of $50.0 on 03/30/2026
    • Evie Koslosky from Goldman Sachs set a target price of $35.0 on 02/13/2026
    • Derik De Bruin from B of A Securities set a target price of $60.0 on 12/15/2025

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles